Evidence map›Paper›PMID 36934138›Full record

ArticleScientific reports2023

Assessing the effectiveness of perimeter lockdowns as a response to epidemics at the urban scale.

Alfonso de Miguel Arribas, Alberto Aleta, Yamir Moreno

Full text read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alfonso de Miguel ArribasInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, 50018, Zaragoza, Spain. alfonso.demiguel.arribas@gmail.com.
Alberto AletaInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, 50018, Zaragoza, Spain.
Yamir MorenoInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, 50018, Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From September 2020 to May 2021 Madrid region (Spain) followed a rather unique non-pharmaceutical intervention (NPI) by establishing a strategy of perimeter lockdowns (PLs) that banned travels to and from areas satisfying certain epidemiological risk criteria. PLs were pursued to avoid harsher restrictions, but some studies have found that the particular implementation by Madrid authorities was rather ineffective. Based on Madrid's case, we devise a general, minimal framework to investigate the PLs effectiveness by using a data-driven metapopulation epidemiological model of a city, and explore under which circumstances the PLs could be a good NPI. The model is informed with real mobility data from Madrid to contextualize its results, but it can be generalized elsewhere. The lowest lockdown activation threshold [Formula: see text] considered (14-day cumulative incidence rate of 20 cases per every [Formula: see text] inhabitants) shows a prevalence reduction [Formula: see text] with respect to the scenario [Formula: see text], more akin to the case of Madrid, and assuming no further mitigation. Only the combination of [Formula: see text] and mobility reduction [Formula: see text] can avoid PLs for more than [Formula: see text] of the system. The combination of low [Formula: see text] and strong local transmissibility reduction is key to minimize the impact, but the latter is harder to achieve given that we assume a situation with highly mitigated transmission, resembling the one observed during the second wave of COVID-19 in Madrid. Thus, we conclude that a generalized lockdown is hard to avoid under any realistic setting if only this strategy is applied.

Indexed as

COVID-19EpidemicsCommunicable Disease ControlHumansSpain

Identifiers

PMID36934138
PMCPMC10024032

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read17
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.